fluconazole has been researched along with metronidazole in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (5.71) | 18.2507 |
2000's | 21 (30.00) | 29.6817 |
2010's | 40 (57.14) | 24.3611 |
2020's | 5 (7.14) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
Gupta, G; Jain, A; Jain, RK; Kiran Kumar, ST; Kumar, L; Kumar, M; Maikhuri, JP; Sharma, VL; Shukla, PK | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Gupta, G; Jain, A; Kumar, A; Kumar, L; Kumar, R; Lal, N; Maikhuri, JP; Sarswat, A; Sharma, VL; Shukla, PK; Verma, V | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Gupta, G; Jain, A; Kiran Kumar, ST; Kumar, L; Kumar, S; Lal, N; Maikhuri, JP; Pandey, AK; Sarswat, A; Sharma, VL; Shukla, PK | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bala, V; Gupta, G; Jangir, S; Kumar, L; Kumar, V; Kushwaha, B; Lal, N; Maikhuri, JP; Pandey, AK; Sarswat, A; Sharma, VL; Shukla, PK; Siddiqi, MI | 1 |
Bala, V; Bhatta, RS; Chandasana, H; Chhonker, YS; Gupta, G; Gupta, S; Jangir, S; Krishna, A; Krishna, S; Kushwaha, B; Maikhuri, JP; Mandalapu, D; Rawat, K; Sankhwar, SN; Sharma, VL; Shukla, PK; Siddiqi, MI; Singh, M; Tripathi, R | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bala, V; Gupta, G; Jain, A; Jangir, S; Krishna, S; Kumar, L; Kushwaha, B; Lal, N; Maikhuri, JP; Mandalapu, D; Pandey, AK; Rawat, T; Sarswat, A; Sharma, VL; Shukla, PK; Siddiqi, MI | 1 |
Chandrasekaran, B; Cherukupalli, S; Hampannavar, GA; Karpoormath, R; Palakollu, VN; Thapliyal, N | 1 |
Gao, WW; Gopala, L; Li, ZZ; Tangadanchu, VKR; Zhou, CH | 1 |
Chauhan, BS; Goyani, R; Gupta, G; Gupta, S; Krishna, S; Kumar, B; Kushwaha, B; Lal, J; Maikhuri, JP; Mandalapu, D; Sashidhara, KV; Sharma, VL; Shukla, M; Shukla, PK; Siddiqi, MI; Singh, P; Srivastava, N; Tripathi, R | 1 |
Ba, Y; Hou, X; Wang, S; Xu, Z; Yang, H; Zhang, J | 1 |
Beteck, RM; Jesumoroti, OJ; Legoabe, LJ; Patel, OPS | 1 |
Daujat, M; Domergue, J; Fabre, I; Joyeux, H; Maurel, P; Maurice, M; Pichard, L | 1 |
Durham, T; Johansson, SL; Kaufman, L; Swindells, S | 1 |
Croucher, PE; Dockerty, WG; Sonnex, C | 1 |
Bańcer, M; Bejm, J; Peterek, J; Stawarz, B; Sulik, M; Zabkowski, T | 1 |
Beelen, DW; Dermoumi, H; Elmaagacli, A; Heintschel von Heinegg, E; Müller, KD; Peceny, R; Runde, V; Schaefer, UW; Trenschel, R | 1 |
Ressel, GW | 1 |
Avorn, J; Fischer, MA; Solomon, DH; Teich, JM | 1 |
Arora, R; Batra, S; Malhotra, M; Sharma, JB; Sharma, S | 1 |
Chanana, C; Mittal, S; Raina, U; Sharma, JB | 1 |
Karabetsos, D; Koutentakis, D; Ntouros, D; Vakis, A | 1 |
Ortiz-Ibarra, J; Reyna-Figueroa, J; Villagrana-Zesati, R | 1 |
Ditmer, D; Feldstein, AC; Krall, M; Perrin, N; Platt, R; Simon, SR; Sittig, DF; Smith, DH; Soumerai, SB; Yang, X | 1 |
Blikslager, AT; Davis, JL; Little, D; Papich, MG | 1 |
Agyarko-Poku, T; Asamoah-Adu, C; Deslandes, S; Diakité, S; Frost, E; Khonde, N; Labbé, AC; Pépin, J; Sobela, F; Sylla, M | 1 |
Baeten, JM; Chohan, V; Hassan, WM; Holmes, KK; Jaoko, W; Kiarie, J; Kurth, AE; Lavreys, L; Mandaliya, K; McClelland, RS; Ndinya-Achola, JO; Richardson, BA | 1 |
Kekulé, AS; Kreft, B; Lübbert, C; Marsch, WC; Oehme, A | 1 |
Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH | 1 |
Khan, AS; Khan, S; Sheikh, Z | 1 |
Balkus, JE; Farquhar, C; Gitau, R; Jaoko, W; Kiarie, J; Mandaliya, K; Marrazzo, J; Masese, L; McClelland, RS; Richardson, BA | 1 |
Li, B; Yu, K; Zhang, T | 1 |
Andreeva, IV; Belikov, AN; Evstaf'ev, VV; Fokin, AA; Grinev, AV; Khrianin, AA; Kirpicheva, NN; Korolev, SV; Kozlov, SN; Serdiutskaia, MV; Stetsiuk, OU | 1 |
Al Omran, Y; Anwuzia-Iwegbu, C; Heaford, A | 1 |
Balkus, JE; McClelland, RS; Mochache, V | 1 |
Dettloff, J; Kassim, A; Reddy, SB; Reddy, VB; Waldman, L | 1 |
Buffon, R; Manzoor, S; Rossi, AV | 1 |
Hersh, EV; Moore, PA | 1 |
Brandsborg, E; Hammarström, L; Larsson, PG; Marcotte, H; Pendharkar, S | 1 |
Ali, I; Babik, JM; Brondfield, MN; Cope, JR; DeMarco, T; Doernberg, SB; Hilts-Horeczko, A; Klein, L; Matanock, A; Reid, MJ; Ritter, JM; Rutishauser, RL; Tang, J | 1 |
Pararajasingam, A; Uwagwu, J | 1 |
Domenici, L; Giorgini, M; Palma, E; Panici, PB; Pierangeli, A; Recine, N | 1 |
Geballa-Koukoula, A; Geballa-Koukoulas, K; Gennimata, D; Kavvalou, E; Panderi, I; Panteri-Petratou, E; Vourna, P; Zervas, K | 1 |
Aldrovandi, GM; Cunningham, NJ; Kordy, K; Lee, DJ; Li, F; Romeo, AC; Saavedra, M; Tobin, N; Zabih, S | 1 |
Nayak, C; Tambe, S; Zambare, U | 1 |
Battini, N; Hu, YY; Yadav Bheemanaboina, RR; Zhou, CH | 1 |
Bastianpillai, J; Chaudhry, S; Vijendren, A | 1 |
Cianci, A; Corsello, S; Ettore, G; Genovese, C; Mattana, P; Tempera, G | 1 |
Goh, LH; Logan, S; Sim, M | 1 |
Achachi, N; Matmour, D; Toumi, H | 1 |
Akbar, N; Hussain, K; Khalid, M; Khan, NA; Shah, MR; Siddiqui, R | 1 |
Arriaga-García, FJ; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-González, LF; Rodríguez-Báez, AS; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
8 review(s) available for fluconazole and metronidazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
Topics: Animals; Chemistry Techniques, Synthetic; Humans; Pyrazoles; Pyrimidines | 2017 |
Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
Topics: Anti-Bacterial Agents; Bacterial Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles | 2019 |
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiprotozoal Agents; Drug Development; Humans; Hypoglycemic Agents; Metronidazole | 2021 |
Oral histoplasmosis in a patient infected with HIV. A case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Fluconazole; Histoplasmosis; Humans; Male; Metronidazole; Mouth Diseases | 1994 |
Three Serious Drug Interactions that Every Dentist Should Know About.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Bradycardia; Cytochrome P-450 CYP2C9; Dental Care; Drug Interactions; Epinephrine; Fluconazole; Hemorrhage; Humans; International Normalized Ratio; Lithium; Metronidazole; Propranolol; Warfarin | 2015 |
Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature.
Topics: Acanthamoeba; Amebiasis; Amebicides; Amphotericin B; Anti-Bacterial Agents; Antilymphocyte Serum; Biopsy; Cardiomyopathies; Drugs, Investigational; Endoscopy; Female; Fluconazole; Flucytosine; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Magnetic Resonance Imaging; Metacarpal Bones; Metronidazole; Middle Aged; Phosphorylcholine; Polymerase Chain Reaction; Radiography; Sinusitis; Skin | 2017 |
Combined systemic (fluconazole) and topical (metronidazole + clotrimazole) therapy for a new approach to the treatment and prophylaxis of recurrent candidiasis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Probiotics; Recurrence | 2019 |
10 trial(s) available for fluconazole and metronidazole
Article | Year |
---|---|
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Bacteria, Anaerobic; Bone Marrow Transplantation; Candidiasis; Cause of Death; Ciprofloxacin; Disease Susceptibility; Female; Fluconazole; Fungemia; Fungi; Hematologic Neoplasms; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; Intestinal Diseases; Intestines; Male; Metronidazole; Middle Aged; Mycoses; Neuroaspergillosis; Opportunistic Infections; Premedication; Prospective Studies; Superinfection; Transplantation Conditioning; Treatment Outcome | 2000 |
Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial.
Topics: Adolescent; Adult; Azithromycin; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Pelvic Inflammatory Disease; Prospective Studies; Tinidazole | 2003 |
Comparative efficacy of two regimens in syndromic management of lower genital infections.
Topics: Administration, Intravaginal; Adult; Anti-Infective Agents, Local; Azithromycin; Clotrimazole; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Pruritus; Vaginitis | 2006 |
Short-term therapy for mixed vaginal infections.
Topics: Administration, Oral; Antifungal Agents; Antiprotozoal Agents; Antitrichomonal Agents; Candidiasis, Vulvovaginal; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Metronidazole; Patient Compliance; Tinidazole; Treatment Outcome; Trichomonas Vaginitis; Vaginosis, Bacterial | 2006 |
Reducing warfarin medication interactions: an interrupted time series evaluation.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Drug Interactions; Drug Prescriptions; Education, Medical, Continuing; Female; Fluconazole; Health Maintenance Organizations; Humans; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Sulfamethoxazole; Warfarin | 2006 |
The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa.
Topics: Adolescent; Adult; Africa, Western; Animals; Anti-Infective Agents; Antifungal Agents; Antitrichomonal Agents; Candida; Child; Clotrimazole; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Mycoplasma genitalium; Neisseria gonorrhoeae; Sex Work; Syndrome; Tinidazole; Treatment Outcome; Trichomonas vaginalis; Vaginal Discharge | 2006 |
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.
Topics: Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; HIV Infections; HIV-1; Humans; Incidence; Kenya; Lactobacillus; Metronidazole; Middle Aged; Placebos; Sex Work; Trichomonas Vaginitis; Vagina; Vaginosis, Bacterial | 2008 |
The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and Lactobacillus colonization.
Topics: Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Cohort Studies; Female; Fluconazole; Follow-Up Studies; Humans; Incidence; Kenya; Lactobacillus; Metronidazole; Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Work; Treatment Outcome; Vagina; Vaginosis, Bacterial; Young Adult | 2012 |
Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Topics: Administration, Intravaginal; Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Carrier State; Clindamycin; Drug Therapy, Combination; Female; Fluconazole; Humans; Lactobacillus; Metronidazole; Middle Aged; Probiotics; Treatment Outcome; Vagina; Vaginosis, Bacterial; Young Adult | 2015 |
Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.
Topics: Administration, Intravaginal; Adult; Female; Fluconazole; Humans; Lacticaseibacillus rhamnosus; Metronidazole; Microbiota; Papillomavirus Infections; Probiotics; Treatment Outcome; Vagina; Vaginosis, Bacterial | 2018 |
52 other study(ies) available for fluconazole and metronidazole
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Carbodithioic acid esters of fluoxetine, a novel class of dual-function spermicides.
Topics: Animals; Esters; Fluoxetine; Fungi; Spermatocidal Agents; Trichomonas vaginalis | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Imidazole derivatives as possible microbicides with dual protection.
Topics: Animals; Anti-Infective Agents; Cell Survival; Fungi; HeLa Cells; Humans; Imidazoles; Male; Microbial Sensitivity Tests; Spermatozoa; Trichomonas vaginalis | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Design and synthesis of 3-(azol-1-yl)phenylpropanes as microbicidal spermicides for prophylactic contraception.
Topics: Anti-Infective Agents; Antifungal Agents; Contraceptive Agents, Female; Drug Design; Female; HeLa Cells; Humans; Lactobacillus; Propane; Spermatocidal Agents; Structure-Activity Relationship; Trichomonas vaginalis | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Azole-carbodithioate hybrids as vaginal anti-Candida contraceptive agents: design, synthesis and docking studies.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Candida; Drug Design; Escherichia coli; HeLa Cells; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Sulfhydryl Compounds; Trichomonas vaginalis | 2013 |
N-Alkyl/aryl-4-(3-substituted-3-phenylpropyl)piperazine-1-carbothioamide as dual-action vaginal microbicides with reverse transcriptase inhibition.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Dose-Response Relationship, Drug; Female; HeLa Cells; Humans; Lactobacillus acidophilus; Male; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Parasitic Sensitivity Tests; Piperazines; Rabbits; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Spermatocidal Agents; Spermatozoa; Structure-Activity Relationship; Thioamides; Trichomonas vaginalis; Vagina | 2015 |
Role of disulfide linkage in action of bis(dialkylaminethiocarbonyl)disulfides as potent double-Edged microbicidal spermicide: Design, synthesis and biology.
Topics: Animals; Anti-Infective Agents; Candida; Disulfides; Male; Mice; Rabbits; Spermatocidal Agents; Spermatozoa; Trichomonas vaginalis | 2016 |
Discovery of novel nitroimidazole enols as Pseudomonas aeruginosa DNA cleavage agents.
Topics: Albumins; Anti-Bacterial Agents; DNA Cleavage; DNA Replication; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Discovery; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Molecular Structure; Nitroimidazoles; Pseudomonas aeruginosa; Quantum Theory; Structure-Activity Relationship | 2017 |
Substituted carbamothioic amine-1-carbothioic thioanhydrides as novel trichomonicidal fungicides: Design, synthesis, and biology.
Topics: Carbonic Anhydrases; Dose-Response Relationship, Drug; Drug Design; Fungicides, Industrial; Metronidazole; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Sulfhydryl Compounds; Trichomonas | 2018 |
Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture.
Topics: Blotting, Northern; Cells, Cultured; Clotrimazole; Cytochrome P-450 Enzyme System; Fluconazole; Humans; Imidazoles; Kinetics; Liver; Metronidazole; Miconazole; Microsomes, Liver; Mixed Function Oxygenases; RNA; RNA, Messenger | 1992 |
Balanoposthitis associated with the presence of subpreputial "smegma stones".
Topics: Adult; Antifungal Agents; Balanitis; Calculi; Fluconazole; Humans; Hygiene; Male; Metronidazole; Smegma | 1997 |
[The results of treatment of chronic prostatitis on the background of anaerobic bacterial and fungal infections].
Topics: Adolescent; Adult; Anti-Infective Agents; Antifungal Agents; Bacterial Infections; Chronic Disease; Fluconazole; Humans; Male; Metronidazole; Prostatitis | 1999 |
CDC releases 2002 guidelines for treating STDs: Part I. Diseases characterized by vaginal discharge and PID.
Topics: Anti-Infective Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Metronidazole; Pelvic Inflammatory Disease; Sexually Transmitted Diseases; Trichomonas Vaginitis; Vaginal Discharge; Vaginosis, Bacterial | 2002 |
Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients.
Topics: Administration, Oral; Amiodarone; Drug Therapy, Computer-Assisted; Fluconazole; Humans; Infusions, Intravenous; Levofloxacin; Medication Systems, Hospital; Metronidazole; Ofloxacin; Practice Patterns, Physicians'; Ranitidine; Reminder Systems | 2003 |
Intracerebral CSF collection mimicking cerebral abscess in a patient suffering from cryptococcal meningitis.
Topics: Acyclovir; Aged; Amphotericin B; Anti-Infective Agents; Brain Abscess; Ceftriaxone; Cerebrospinal Fluid; Cerebrospinal Fluid Pressure; Diagnosis, Differential; Drainage; Fluconazole; Humans; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Metronidazole; Spinal Puncture; Teicoplanin | 2005 |
Mucosal permeability of water-soluble drugs in the equine jejunum: a preliminary investigation.
Topics: Animals; Anti-Infective Agents; Biological Availability; Cephalexin; Fluconazole; Fluoroquinolones; Horses; Intestinal Mucosa; Jejunum; Linear Models; Metronidazole; Permeability; Quinolones; Solubility | 2006 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Fever of Unknown Origin; Fluconazole; Giardia lamblia; Giardiasis; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; Immunoblotting; Lymphatic Diseases; Male; Metronidazole; Omeprazole | 2010 |
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained.
Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin | 2011 |
Lingua villosa nigra.
Topics: Anti-Infective Agents; Antifungal Agents; Candidiasis; Clavulanic Acid; Female; Fluconazole; Humans; Metronidazole; Middle Aged; Pelvic Infection; Postoperative Complications; Tongue, Hairy; Treatment Outcome | 2011 |
Direct rapid analysis of multiple PPCPs in municipal wastewater using ultrahigh performance liquid chromatography-tandem mass spectrometry without SPE pre-concentration.
Topics: Acyclovir; Benzophenones; Carbamazepine; Chromatography, High Pressure Liquid; Fluconazole; Fluoxetine; Hong Kong; Metronidazole; Parabens; Pharmaceutical Preparations; Ranitidine; Sewage; Solid Phase Extraction; Sunscreening Agents; Tandem Mass Spectrometry | 2012 |
[Diagnostic and treatment patterns in management of male patients with nongonococcal urethritis: results of Russian multicentral cross-sectional study].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiprotozoal Agents; Azithromycin; Ceftriaxone; Chlamydia trachomatis; Cross-Sectional Studies; Doxycycline; Fluconazole; Guideline Adherence; Humans; Josamycin; Male; Metronidazole; Middle Aged; Mycoplasma genitalium; Mycoplasma hominis; Ofloxacin; Polymerase Chain Reaction; Practice Guidelines as Topic; Retrospective Studies; Russia; Trichomonas vaginalis; Ureaplasma urealyticum; Urethra; Urethritis | 2012 |
Against all odds. Conservative management of Boerhaave's syndrome.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Bacterial Agents; Antifungal Agents; Drainage; Esophageal Perforation; Fluconazole; Humans; Male; Mediastinal Diseases; Metronidazole; Pantoprazole; Parenteral Nutrition; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pleural Effusion; Proton Pump Inhibitors | 2014 |
Periodic presumptive treatment for women with prevalent vaginal infections: secondary analysis of data from a randomized controlled trial.
Topics: Adult; Anti-Infective Agents; Candidiasis, Vulvovaginal; Chemoprevention; Female; Fluconazole; Humans; Kenya; Metronidazole; Prevalence; Randomized Controlled Trials as Topic; Sex Workers; Treatment Outcome; Trichomonas Vaginitis; Vaginosis, Bacterial | 2014 |
Neutrophilic Fixed Drug Eruption.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Drug Eruptions; Female; Fluconazole; Humans; Metronidazole; Naproxen; Neutrophils; Pregnancy; Pregnancy Complications | 2015 |
Molecularly imprinted solid phase extraction of fluconazole from pharmaceutical formulations.
Topics: Acetonitriles; Fluconazole; Imidazoles; Methacrylates; Metronidazole; Miconazole; Molecular Imprinting; Polymers; Solid Phase Extraction | 2015 |
Topics: Aged; Anti-Bacterial Agents; Colony Count, Microbial; Drainage; Female; Fluconazole; Humans; Immunocompromised Host; Lactobacillus; Lethargy; Linezolid; Liver Abscess; Metronidazole; Microbial Sensitivity Tests; Pleural Effusion; Probiotics; Sepsis; Treatment Outcome; Venous Thrombosis | 2017 |
A porous graphitized carbon LC-ESI/MS method for the quantitation of metronidazole and fluconazole in breast milk and human plasma.
Topics: Acetonitriles; Chromatography, Liquid; Female; Fluconazole; Graphite; Humans; Limit of Detection; Linear Models; Male; Metronidazole; Milk, Human; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2018 |
Combination Antibiotics Improves Disease Activity and Alters Microbial Communities in Children With Ulcerative Colitis.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Child; Colitis, Ulcerative; Doxycycline; Female; Fluconazole; Gastrointestinal Microbiome; Humans; Male; Metronidazole; Retrospective Studies; Vancomycin; Young Adult | 2018 |
Nodulo-ulcerative and erythrodermic secondary syphilis in human immunodeficiency virus-infected individuals.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Chancre; Coinfection; Fluconazole; HIV Seropositivity; Humans; Injections, Intravenous; Male; Metronidazole; Penicillins; Skin Ulcer; Syphilis; Treatment Outcome | 2019 |
Sulfonamide-Derived Four-Component Molecular Hybrids as Novel DNA-Targeting Membrane Active Potentiators against Clinical Escherichia coli.
Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Carbonic Anhydrases; Cell Membrane Permeability; Cell Survival; DNA, Bacterial; Drug Compounding; Drug Resistance, Bacterial; Drug Resistance, Fungal; Drug Therapy, Combination; Escherichia coli; Ethanol; Fluconazole; Humans; Hydrogen Bonding; Isoenzymes; MCF-7 Cells; Metronidazole; Models, Molecular; Molecular Docking Simulation; Norfloxacin; Piperazine; Sulfonamides | 2019 |
Rare case of a 3-year-old with
Topics: Administration, Intravenous; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candidiasis; Ceftriaxone; Child, Preschool; Facial Paralysis; Female; Fluconazole; Humans; Magnetic Resonance Imaging; Mastoid; Mastoidectomy; Metronidazole; Osteomyelitis; Skull Base; Tomography, X-Ray Computed | 2019 |
Vaginal discharge: evaluation and management in primary care.
Topics: Anti-Infective Agents; Antifungal Agents; Female; Fluconazole; Humans; Metronidazole; Primary Health Care; Sexually Transmitted Diseases; Singapore; Vaginal Discharge | 2020 |
Quality of Active Pharmaceutical Ingredients Present on Algerian Soil: Control of Impurities of Ciprofloxacin, Metronidazole and Fluconazole.
Topics: Algeria; Ciprofloxacin; Drug Contamination; Fluconazole; Metronidazole; Pharmaceutical Preparations; Soil | 2022 |
Azole and 5-nitroimidazole based nanoformulations are potential antiamoebic drug candidates against brain-eating amoebae.
Topics: Amebicides; Amoeba; Antiprotozoal Agents; Azoles; Brain; Fluconazole; Humans; Itraconazole; Metronidazole; Naegleria fowleri | 2023 |
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Clindamycin; Critical Illness; Fluconazole; Humans; Linezolid; Meropenem; Metronidazole; Neoplasms; Piperacillin; Vancomycin | 2023 |